相关实验视频
Updated: Jun 19, 2025
13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
134.6K
具有抗神经素155抗体的耐治疗自身免疫结节病:一个病例报告
Teodors Talers1, Daina Pastare1,2, Guntis Karelis1,2
1Riga Stradins University, Riga, Latvia.
Frontiers in human neuroscience
|July 24, 2024
概括
一名年轻男子手臂/腿部软弱和感官丧失,被诊断患有神经素155抗体相关疾病. 标准治疗失败了,rituximab只提供了部分缓解,表明需要进一步的治疗策略.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经免疫学 神经免疫学
背景情况:
- 神经系统疾病的特征是肢体逐渐衰弱和感觉障碍,需要准确的诊断和有效的治疗.
- 自身免疫性神经病变,特别是那些由特定抗体介导的,具有独特的诊断和治疗挑战.
研究的目的:
- 报告一种Neurofascin 155抗体相关的神经病变的病例.
- 描述这种罕见疾病患者的临床表现,诊断过程和治疗反应.
主要方法:
- 一个先前健康的20多岁的男性的临床病例介绍.
- 对诊断调查的审查,包括对神经素155.5的抗体测试.
- 治疗干预措施的文档:皮质类固醇,血酶,静脉注射免疫球蛋白,修复剂和皮下免疫球蛋白.
主要成果:
- 患者呈现出渐进的手臂和腿部软弱和远端低.
- 最初用皮质类固醇,血酶和静脉注射免疫球蛋白治疗是无效的.
- 对神经素155抗体的检测指导了随后的治疗.
- 利图西马布治疗导致部分改善,持续治疗结合利图西马布和皮下免疫球蛋白.
结论:
- 神经素155抗体相关的神经病变是一种独特的临床实体,可能对传统疗法没有反应.
- 利图西马布显示出潜在但有限的疗效,突出了对这种疾病的优化治疗方案的需求.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.4K
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
35.8K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
01:15Myasthenia Gravis: Diagnostic Tests
732
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
732